Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
GenEdit is a privately held biotechnology company focused on developing innovative genetic medicines through its proprietary NanoGalaxy™ platform. This platform utilizes polymer nanoparticles to precisely deliver therapeutic genetic payloads, such as DNA, RNA, and CRISPR-Cas9, to specific tissues and cells. GenEdit aims to overcome the limitations of current viral and lipid-based delivery systems by offering a safer, more targeted, and re-dosable approach for treating a wide range of genetic diseases and cancers.
The headquarters serves as the central hub for GenEdit's research and development, corporate operations, strategic partnerships, and administrative functions. It houses state-of-the-art laboratories for polymer chemistry, nanoparticle formulation, and preclinical studies.
Modern laboratory facilities equipped for advanced gene therapy research, collaborative workspaces designed to foster innovation, and its location within a leading U.S. biotech cluster.
GenEdit fosters a dynamic, innovative, and science-driven work culture. The environment is collaborative, with a strong emphasis on scientific excellence, problem-solving, and a shared mission to develop impactful therapies for patients.
The South San Francisco headquarters is crucial for GenEdit's operations, enabling cutting-edge research and development of its NanoGalaxy™ platform. Its location provides strategic advantages in talent acquisition, industry networking, and access to specialized resources.
GenEdit's primary operations, including research and development, are currently centered in the United States. While its physical footprint is concentrated, the company engages with the global scientific community through collaborations, participation in international conferences, and aims for its therapeutic innovations to eventually have a worldwide impact on patient care.
611 Gateway Blvd, Suite 120
South San Francisco
CA
USA
No additional office locations available.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, GenEdit' leadership includes:
GenEdit has been backed by several prominent investors over the years, including:
In the past 12 months (mid-2023 to mid-2024), GenEdit significantly bolstered its scientific leadership with the appointment of Dr. Aaron Sato as Chief Scientific Officer. This key hire underscores the company's commitment to advancing its innovative NanoGalaxy™ platform. No major executive departures have been publicly announced during this period.
Discover the tools GenEdit uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
GenEdit likely follows standard corporate email address patterns. The most common format is typically the first initial of the first name followed by the last name.
[first_initial][last]@genedit.com
Format
klee@genedit.com (example for Kunwoo Lee)
Example
75%
Success rate
Business Wire • November 14, 2023
GenEdit secured $24 million in Series A2 financing. The funding will be used to advance its NanoGalaxy™ platform and pipeline of genetic medicines, focusing on systemic delivery to diverse tissues....more
Business Wire • July 11, 2023
GenEdit announced the appointment of Aaron Sato, Ph.D., as its Chief Scientific Officer. Dr. Sato brings extensive experience in drug discovery and development to lead GenEdit's research initiatives....more
GlobeNewswire • May 18, 2023
GenEdit presented promising preclinical data at the American Society of Gene & Cell Therapy (ASGCT) 2023 Annual Meeting, showcasing the potential of its NanoGalaxy™ platform for delivering gene editing therapies to the central nervous system....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including GenEdit, are just a search away.